Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-24-002384
Filing Date
2024-10-29
Accepted
2024-10-29 16:32:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D sc13da107422moln_10292024.htm SC 13D/A 283576
  Complete submission text file 0000921895-24-002384.txt   285239
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952
Business Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952 41 44 755 77 00
MOLECULAR PARTNERS AG (Subject) CIK: 0001745114 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92857 | Film No.: 241406225
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)